Acetylcysteine News

Antioxidant avoids contrast nephropathy

Acetylcysteine prevents contrast-induced nephropathy in patients undergoing primary angioplasty, a randomized trial indicates.

The dose-dependent benefits of the powerful antioxidant were accompanied by improved hospital...

N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty

Patients with acute myocardial infarction undergoing primary angioplasty are at high risk for contrast-medium–induced nephropathy because of hemodynamic instability, the need for a high volume of contrast medium, and the lack of...

Contrast-Induced Nephropathy in Angioplasty Reduced With N-Acetylcysteine

N-acetylcysteine may prevent contrast-induced nephropathy in patients undergoing angioplasty, according to the results of a randomized study reported in the June 29 issue of The New England Journal of Medicine.

Antioxidant could prevent HIV-associated dementia

Experiments show that N-acetylcysteine amide can block cell death in a model of HIV-associated dementia.

New antioxidant may help prevent AIDS dementia, says UMR researcher

A newly redesigned antioxidant may play a critical role in preventing HIV-1-associated dementia, says a University of Missouri-Rolla chemist. Her research will be published in an upcoming issue of the journal Experimental...